MYC and lymphoma: Other clinical and pathological factors were also relevant to lower survival ratio, including Myc protein positivity, double expression lymphoma (DEL), B symptoms, ENI ≥ 2, elevated LDH level, poor PS, advanced Ann Arbor stage, high-risk IPI, and non-GCB subtype (Fig. 1c-1h, Fig. 2a-2h, Fig. 3a-3f).